Global Oral Mesalazine Supply, Demand and Key Producers, 2024-2030

Description

The global Oral Mesalazine market size is expected to reach $ 106.2 million by 2030, rising at a market growth of 3.5% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally.

This report studies the global Oral Mesalazine demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oral Mesalazine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Mesalazine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oral Mesalazine total market, 2019-2030, (USD Million)
Global Oral Mesalazine total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Oral Mesalazine total market, key domestic companies and share, (USD Million)
Global Oral Mesalazine revenue by player and market share 2019-2024, (USD Million)
Global Oral Mesalazine total market by Type, CAGR, 2019-2030, (USD Million)
Global Oral Mesalazine total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Oral Mesalazine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Shire, Salix Pharmaceuticals, Ferring Global, Teva Pharmaceutical Industries, Morningside Healthcare, Dr. Falk Pharma UK, Nogra Pharma Limited and Tillotts Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Mesalazine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Oral Mesalazine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oral Mesalazine Market, Segmentation by Type
    Tablets
    Capsules
    Granule

Global Oral Mesalazine Market, Segmentation by Application
    Ulcerative Colitis
    Crohn's Disease
    Inflammatory Bowel Disease
    Others

Companies Profiled:
    AbbVie
    Shire
    Salix Pharmaceuticals
    Ferring Global
    Teva Pharmaceutical Industries
    Morningside Healthcare
    Dr. Falk Pharma UK
    Nogra Pharma Limited
    Tillotts Pharma

Key Questions Answered
1. How big is the global Oral Mesalazine market?
2. What is the demand of the global Oral Mesalazine market?
3. What is the year over year growth of the global Oral Mesalazine market?
4. What is the total value of the global Oral Mesalazine market?
5. Who are the major players in the global Oral Mesalazine market?

Table of Contents

1 Supply Summary
    1.1 Oral Mesalazine Introduction
    1.2 World Oral Mesalazine Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Oral Mesalazine Total Market by Region (by Headquarter Location)
        1.3.1 World Oral Mesalazine Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Oral Mesalazine Market Size (2019-2030)
        1.3.3 China Oral Mesalazine Market Size (2019-2030)
        1.3.4 Europe Oral Mesalazine Market Size (2019-2030)
        1.3.5 Japan Oral Mesalazine Market Size (2019-2030)
        1.3.6 South Korea Oral Mesalazine Market Size (2019-2030)
        1.3.7 ASEAN Oral Mesalazine Market Size (2019-2030)
        1.3.8 India Oral Mesalazine Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oral Mesalazine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oral Mesalazine Major Market Trends

2 Demand Summary
    2.1 World Oral Mesalazine Consumption Value (2019-2030)
    2.2 World Oral Mesalazine Consumption Value by Region
        2.2.1 World Oral Mesalazine Consumption Value by Region (2019-2024)
        2.2.2 World Oral Mesalazine Consumption Value Forecast by Region (2025-2030)
    2.3 United States Oral Mesalazine Consumption Value (2019-2030)
    2.4 China Oral Mesalazine Consumption Value (2019-2030)
    2.5 Europe Oral Mesalazine Consumption Value (2019-2030)
    2.6 Japan Oral Mesalazine Consumption Value (2019-2030)
    2.7 South Korea Oral Mesalazine Consumption Value (2019-2030)
    2.8 ASEAN Oral Mesalazine Consumption Value (2019-2030)
    2.9 India Oral Mesalazine Consumption Value (2019-2030)

3 World Oral Mesalazine Companies Competitive Analysis
    3.1 World Oral Mesalazine Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Oral Mesalazine Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Oral Mesalazine in 2023
        3.2.3 Global Concentration Ratios (CR8) for Oral Mesalazine in 2023
    3.3 Oral Mesalazine Company Evaluation Quadrant
    3.4 Oral Mesalazine Market: Overall Company Footprint Analysis
        3.4.1 Oral Mesalazine Market: Region Footprint
        3.4.2 Oral Mesalazine Market: Company Product Type Footprint
        3.4.3 Oral Mesalazine Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Oral Mesalazine Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Oral Mesalazine Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Oral Mesalazine Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Oral Mesalazine Consumption Value Comparison
        4.2.1 United States VS China: Oral Mesalazine Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Oral Mesalazine Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Oral Mesalazine Companies and Market Share, 2019-2024
        4.3.1 United States Based Oral Mesalazine Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Oral Mesalazine Revenue, (2019-2024)
    4.4 China Based Companies Oral Mesalazine Revenue and Market Share, 2019-2024
        4.4.1 China Based Oral Mesalazine Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Oral Mesalazine Revenue, (2019-2024)
    4.5 Rest of World Based Oral Mesalazine Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Oral Mesalazine Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Oral Mesalazine Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Oral Mesalazine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Tablets
        5.2.2 Capsules
        5.2.3 Granule
    5.3 Market Segment by Type
        5.3.1 World Oral Mesalazine Market Size by Type (2019-2024)
        5.3.2 World Oral Mesalazine Market Size by Type (2025-2030)
        5.3.3 World Oral Mesalazine Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Oral Mesalazine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Ulcerative Colitis
        6.2.2 Crohn's Disease
        6.2.3 Inflammatory Bowel Disease
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Oral Mesalazine Market Size by Application (2019-2024)
        6.3.2 World Oral Mesalazine Market Size by Application (2025-2030)
        6.3.3 World Oral Mesalazine Market Size by Application (2019-2030)

7 Company Profiles
    7.1 AbbVie
        7.1.1 AbbVie Details
        7.1.2 AbbVie Major Business
        7.1.3 AbbVie Oral Mesalazine Product and Services
        7.1.4 AbbVie Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 AbbVie Recent Developments/Updates
        7.1.6 AbbVie Competitive Strengths & Weaknesses
    7.2 Shire
        7.2.1 Shire Details
        7.2.2 Shire Major Business
        7.2.3 Shire Oral Mesalazine Product and Services
        7.2.4 Shire Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Shire Recent Developments/Updates
        7.2.6 Shire Competitive Strengths & Weaknesses
    7.3 Salix Pharmaceuticals
        7.3.1 Salix Pharmaceuticals Details
        7.3.2 Salix Pharmaceuticals Major Business
        7.3.3 Salix Pharmaceuticals Oral Mesalazine Product and Services
        7.3.4 Salix Pharmaceuticals Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Salix Pharmaceuticals Recent Developments/Updates
        7.3.6 Salix Pharmaceuticals Competitive Strengths & Weaknesses
    7.4 Ferring Global
        7.4.1 Ferring Global Details
        7.4.2 Ferring Global Major Business
        7.4.3 Ferring Global Oral Mesalazine Product and Services
        7.4.4 Ferring Global Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Ferring Global Recent Developments/Updates
        7.4.6 Ferring Global Competitive Strengths & Weaknesses
    7.5 Teva Pharmaceutical Industries
        7.5.1 Teva Pharmaceutical Industries Details
        7.5.2 Teva Pharmaceutical Industries Major Business
        7.5.3 Teva Pharmaceutical Industries Oral Mesalazine Product and Services
        7.5.4 Teva Pharmaceutical Industries Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
        7.5.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
    7.6 Morningside Healthcare
        7.6.1 Morningside Healthcare Details
        7.6.2 Morningside Healthcare Major Business
        7.6.3 Morningside Healthcare Oral Mesalazine Product and Services
        7.6.4 Morningside Healthcare Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Morningside Healthcare Recent Developments/Updates
        7.6.6 Morningside Healthcare Competitive Strengths & Weaknesses
    7.7 Dr. Falk Pharma UK
        7.7.1 Dr. Falk Pharma UK Details
        7.7.2 Dr. Falk Pharma UK Major Business
        7.7.3 Dr. Falk Pharma UK Oral Mesalazine Product and Services
        7.7.4 Dr. Falk Pharma UK Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Dr. Falk Pharma UK Recent Developments/Updates
        7.7.6 Dr. Falk Pharma UK Competitive Strengths & Weaknesses
    7.8 Nogra Pharma Limited
        7.8.1 Nogra Pharma Limited Details
        7.8.2 Nogra Pharma Limited Major Business
        7.8.3 Nogra Pharma Limited Oral Mesalazine Product and Services
        7.8.4 Nogra Pharma Limited Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Nogra Pharma Limited Recent Developments/Updates
        7.8.6 Nogra Pharma Limited Competitive Strengths & Weaknesses
    7.9 Tillotts Pharma
        7.9.1 Tillotts Pharma Details
        7.9.2 Tillotts Pharma Major Business
        7.9.3 Tillotts Pharma Oral Mesalazine Product and Services
        7.9.4 Tillotts Pharma Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Tillotts Pharma Recent Developments/Updates
        7.9.6 Tillotts Pharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oral Mesalazine Industry Chain
    8.2 Oral Mesalazine Upstream Analysis
    8.3 Oral Mesalazine Midstream Analysis
    8.4 Oral Mesalazine Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oral Mesalazine Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Oral Mesalazine Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Oral Mesalazine Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Oral Mesalazine Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Oral Mesalazine Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Oral Mesalazine Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Oral Mesalazine Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Oral Mesalazine Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Oral Mesalazine Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Oral Mesalazine Players in 2023
    Table 12. World Oral Mesalazine Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Oral Mesalazine Company Evaluation Quadrant
    Table 14. Head Office of Key Oral Mesalazine Player
    Table 15. Oral Mesalazine Market: Company Product Type Footprint
    Table 16. Oral Mesalazine Market: Company Product Application Footprint
    Table 17. Oral Mesalazine Mergers & Acquisitions Activity
    Table 18. United States VS China Oral Mesalazine Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Oral Mesalazine Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Oral Mesalazine Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Oral Mesalazine Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Oral Mesalazine Revenue Market Share (2019-2024)
    Table 23. China Based Oral Mesalazine Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Oral Mesalazine Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Oral Mesalazine Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Oral Mesalazine Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Oral Mesalazine Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Oral Mesalazine Revenue Market Share (2019-2024)
    Table 29. World Oral Mesalazine Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Oral Mesalazine Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Oral Mesalazine Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Oral Mesalazine Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Oral Mesalazine Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Oral Mesalazine Market Size by Application (2025-2030) & (USD Million)
    Table 35. AbbVie Basic Information, Area Served and Competitors
    Table 36. AbbVie Major Business
    Table 37. AbbVie Oral Mesalazine Product and Services
    Table 38. AbbVie Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. AbbVie Recent Developments/Updates
    Table 40. AbbVie Competitive Strengths & Weaknesses
    Table 41. Shire Basic Information, Area Served and Competitors
    Table 42. Shire Major Business
    Table 43. Shire Oral Mesalazine Product and Services
    Table 44. Shire Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Shire Recent Developments/Updates
    Table 46. Shire Competitive Strengths & Weaknesses
    Table 47. Salix Pharmaceuticals Basic Information, Area Served and Competitors
    Table 48. Salix Pharmaceuticals Major Business
    Table 49. Salix Pharmaceuticals Oral Mesalazine Product and Services
    Table 50. Salix Pharmaceuticals Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Salix Pharmaceuticals Recent Developments/Updates
    Table 52. Salix Pharmaceuticals Competitive Strengths & Weaknesses
    Table 53. Ferring Global Basic Information, Area Served and Competitors
    Table 54. Ferring Global Major Business
    Table 55. Ferring Global Oral Mesalazine Product and Services
    Table 56. Ferring Global Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Ferring Global Recent Developments/Updates
    Table 58. Ferring Global Competitive Strengths & Weaknesses
    Table 59. Teva Pharmaceutical Industries Basic Information, Area Served and Competitors
    Table 60. Teva Pharmaceutical Industries Major Business
    Table 61. Teva Pharmaceutical Industries Oral Mesalazine Product and Services
    Table 62. Teva Pharmaceutical Industries Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Teva Pharmaceutical Industries Recent Developments/Updates
    Table 64. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
    Table 65. Morningside Healthcare Basic Information, Area Served and Competitors
    Table 66. Morningside Healthcare Major Business
    Table 67. Morningside Healthcare Oral Mesalazine Product and Services
    Table 68. Morningside Healthcare Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Morningside Healthcare Recent Developments/Updates
    Table 70. Morningside Healthcare Competitive Strengths & Weaknesses
    Table 71. Dr. Falk Pharma UK Basic Information, Area Served and Competitors
    Table 72. Dr. Falk Pharma UK Major Business
    Table 73. Dr. Falk Pharma UK Oral Mesalazine Product and Services
    Table 74. Dr. Falk Pharma UK Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Dr. Falk Pharma UK Recent Developments/Updates
    Table 76. Dr. Falk Pharma UK Competitive Strengths & Weaknesses
    Table 77. Nogra Pharma Limited Basic Information, Area Served and Competitors
    Table 78. Nogra Pharma Limited Major Business
    Table 79. Nogra Pharma Limited Oral Mesalazine Product and Services
    Table 80. Nogra Pharma Limited Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Nogra Pharma Limited Recent Developments/Updates
    Table 82. Tillotts Pharma Basic Information, Area Served and Competitors
    Table 83. Tillotts Pharma Major Business
    Table 84. Tillotts Pharma Oral Mesalazine Product and Services
    Table 85. Tillotts Pharma Oral Mesalazine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 86. Global Key Players of Oral Mesalazine Upstream (Raw Materials)
    Table 87. Oral Mesalazine Typical Customers
List of Figure
    Figure 1. Oral Mesalazine Picture
    Figure 2. World Oral Mesalazine Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Oral Mesalazine Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Oral Mesalazine Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Oral Mesalazine Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Oral Mesalazine Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Oral Mesalazine Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Oral Mesalazine Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Oral Mesalazine Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Oral Mesalazine Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Oral Mesalazine Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Oral Mesalazine Revenue (2019-2030) & (USD Million)
    Figure 13. Oral Mesalazine Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Oral Mesalazine Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Oral Mesalazine Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Oral Mesalazine Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Oral Mesalazine Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Oral Mesalazine Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Oral Mesalazine Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Oral Mesalazine Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Oral Mesalazine Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Oral Mesalazine Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Oral Mesalazine by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Oral Mesalazine Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Oral Mesalazine Markets in 2023
    Figure 27. United States VS China: Oral Mesalazine Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Oral Mesalazine Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Oral Mesalazine Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Oral Mesalazine Market Size Market Share by Type in 2023
    Figure 31. Tablets
    Figure 32. Capsules
    Figure 33. Granule
    Figure 34. World Oral Mesalazine Market Size Market Share by Type (2019-2030)
    Figure 35. World Oral Mesalazine Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 36. World Oral Mesalazine Market Size Market Share by Application in 2023
    Figure 37. Ulcerative Colitis
    Figure 38. Crohn's Disease
    Figure 39. Inflammatory Bowel Disease
    Figure 40. Others
    Figure 41. Oral Mesalazine Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Companies Mentioned

AbbVie
Shire
Salix Pharmaceuticals
Ferring Global
Teva Pharmaceutical Industries
Morningside Healthcare
Dr. Falk Pharma UK
Nogra Pharma Limited
Tillotts Pharma